Cowen and Company’s Braskem BAK Stock Holding History

Cowen and Company’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,744	Closed	-$218K	–	648
2023 Q2	$218K	Buy	+18,744	New	+$177K	0.02%	208

Other funds holding BAK

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Cowen and Company's BAK Position: Q3 2023 in Review

Cowen and Company sold out of Braskem (BAK) in Q3 2023, closing a stake of 18,744 shares — an estimated $218K sold.

Cowen and Company first reported a position in BAK in Q2 2023 and held it in 1 quarter. The position peaked at $218K in Q2 2023. 52 funds tracked by Wall St. Rank hold BAK as of Q3 2023.

Cowen and Company reported no remaining Braskem position as of Q3 2023 after selling out during the quarter.
Cowen and Company sold 18,744 Braskem shares in Q3 2023, an estimated $218K.
Cowen and Company first reported a position in Braskem in Q2 2023 and held it in 1 quarter.
Cowen and Company's Braskem position peaked at $218K in Q2 2023.
52 funds tracked by Wall St. Rank held Braskem as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.